Geosphere Capitals Arvind Sanger Cautious Optimism on India as Earnings Revival Eyed AIDriven Advertising Potential 20 Boost in Return on Ad Spend Reshapes Ecosystem UK Exports to US Plunge 25 as Trumps Liberation Day Tariffs Reshape Trade Balance Morgan Stanley Adjusts Edison International Price Target Amid April Utility Sector Review JPMorgans Summer Reading List for Affluent Clients Highlights AI Leadership and Unexpected Titles US FirstQuarter GDP Growth Revised Lower to 16 Pace UAN Q1 2026 Earnings Strong EPS of 472 Drives Stock Gain SEE Q4 2025 Earnings EPS Surpasses Expectations Amid Modest Stock Response ACGLN Q1 2026 Earnings EPS Misses Estimates Amid Insurance Market Conditions UHT Q1 2026 Earnings Steady PerShare Results Amidst Stable Healthcare Real Estate Camden Property Trust CPT Q1 2026 Earnings Strong EPS Beat Signals Resilient Multifamily Operations KNSA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Product Growth SolarEdge Technologies SEDG Dips 216 as Resistance Holds Support Levels in Focus BGSF Inc BGSF Slides 323 as Selling Pressure Intensifies Below Resistance Pineapple Financial Inc PAPL Gains Nearly 5 as Stock Pushes Toward Resistance KNRX Faces Pressure Knorex Ltd Tests Key Support Levels After 263 Decline Mid Penn Bancorp MPB Holds Steady Near 323 as Support and Resistance Define Trading Range SGX RegCo Gives Suspended Firms Three Years to Resume Trading or Face Delisting BOF Q1 2026 Earnings EPS Loss of 012 Amid Operational Challenges Xperi Inc XPER Surges 265 as Shares Test Key Moving Averages Mercks Phase 3 TroFuse005 Trial for Endometrial Cancer Meets Dual Primary Endpoints Kimi Antonelli Secures Historic Fourth Consecutive F1 Win in Canada Championship Standings Shift UK Governments Proposed Food Price Caps Spark Industry Backlash Amid Broken System Concerns Avalanche and Sui Futures Launch Expands Crypto Derivatives Landscape UK Government Pledges 120 Million to Support Ceramics Industry Surge in LongDated Treasury Yields Prompts Bond Investors to Rethink RiskFree Assumptions Immunic Appoints Erik Lundgren as CEO Amid Phase 3 Multiple Sclerosis Trial Progress